The Association between Academic Performance and Entry-to-Practice Milestones within a Co-Operative Education PharmD Program
Abstract
:1. Introduction
Program Overview
- CSL is a mandatory non-course degree requirement and milestone in the PharmD program [17]. CSL consists of three phases, preparation, action, and application, aimed at engaging PharmD students in service activities, reflecting on personal and professional goals, and contributing to community health [17].
- The co-op program mandates three employer-paid 16-week full-time work terms, with the initial two work terms occurring in the second year and the final one in the third year [7]. Students can experience various work settings, including primary care, institutional pharmacy, industry, government, and research [7]. They can secure placements through competitive applications and job interviews with school-recruited positions or self-arrangement [7]. Student responsibilities align with the employer’s job description, with terms and passing requirements detailed in Table 1 [7].
- During clinical rotations, students assess patients, address drug-related needs, devise and execute care plans, and co-operate with interprofessional teams to enhance patient outcomes [18]. These unpaid courses require students to complete all three rotation placements within a lottery-assigned region in Ontario [18]. Course numbers correspond to the care setting, including institutional, primary care, and elective rotations [18].
- Additional information on the curriculum is provided in (Figure 1) and in Supplementary Figure S1. A complete list of abbreviations can be found in Supplementary Table S1.
2. Materials and Methods
2.1. Data Collection
2.2. Data Exploration
2.3. Data Analyses
- Integrated Patient-Focused Care series courses: PHARM 220, 221, 222, 223, 320, 321, 323, 324, and 422;
- Professional Practice series courses: PHARM 129, 130, 228, 229, 329, and 330;
- Pharmacokinetics: PHARM 224;
- Co-op work-term scores;
- PharmD rotation scores;
- Midpoint assessment MCQ scores;
- Year 1, 2, 3, and 4 OSCE scores.
2.4. Analysis 1—The Relationship between Student Course and Experiential Education Performance with PEBC Pharmacist Qualifying Examination Performance (Part I MCQ and Part II OSCE)
- Variation 1: OPPCAT only as predictor variable for rotation performance with PEBC Pharmacist Qualifying Examination Part I (MCQ) as the dependent variable;
- Variation 2: OPPCAT only as predictor variable for rotation performance with PEBC Pharmacist Qualifying Examination Part II (OSCE) as the dependent variable;
- Variation 3: Rotation course overall as predictor variable for rotation performance with PEBC Pharmacist Qualifying Examination Part I (MCQ) as the dependent variable;
- Variation 4: Rotation course overall as predictor variable for rotation performance with PEBC Pharmacist Qualifying Examination Part II (OSCE) as the dependent variable.
2.5. Analysis 2—The Relationship between Didactic Courses and Co-Op Performance with Rotation Performance
- Regression 1: OPPCAT only from the first completed rotation as the dependent variable;
- Regression 2: OPPCAT only from the second completed rotation as the dependent variable;
- Regression 3: OPPCAT only from the third completed rotation as the dependent variable;
- Regression 4: PHARM 430 (Primary Care) rotation overall score as the dependent variable;
- Regression 5: PHARM 440 (Institutional) rotation overall score as the dependent variable;
- Regression 6: PHARM 450 (Elective) rotation overall score as the dependent variable.
2.6. Model Diagnostics
2.7. Complimentary Descriptive Analysis
3. Results
3.1. Analysis 1—The Relationship between Student Course and Experiential Education Performance with PEBC Exam Performance (MCQ and OSCE)
3.2. Analysis 2—The Relationship between Didactic Courses and Co-Op Performance with Rotation Performance
3.3. Complimentary Descriptive Analysis
4. Discussion
Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Reinhard, K.; Wynder, M.; Kim, W. Developing Best Practice for Cooperative and Work-Integrated Education: Lessons from Germany, Australia and South Korea. Int. J. Work.-Integr. Learn. 2020, 21, 177–191. [Google Scholar]
- Malau-Aduli, B.S.; Jones, K.; Alele, F.; Adu, M.D.; Drovandi, A.; Knott, G.; Young, L.; Jo, C. Readiness to enter the workforce: Perceptions of health professions students at a regional Australian university. BMC Med. Educ. 2022, 22, 89. [Google Scholar] [CrossRef] [PubMed]
- Austin, Z.; Ensom, M.H. Education of pharmacists in Canada. Am. J. Pharm. Educ. 2008, 72, 128. [Google Scholar] [CrossRef] [PubMed]
- Owen, S.; Stupans, I. Australian pharmacy programme experiential placements: Comprehensive planning for assessment and evaluation. Assess. Eval. High. Education. 2009, 34, 579–594. [Google Scholar] [CrossRef]
- Ajjawi, R.; Tai, J.; Nghia, T.L.H.; Boud, D.; Johnson, L.; Patrick, C.-J. Aligning assessment with the needs of work-integrated learning: The challenges of authentic assessment in a complex context. Assess. Eval. High. Educ. 2020, 45, 304–316. [Google Scholar] [CrossRef]
- Kerr, A.; O’Connor, H.; Pawlikowska, T.; Gallagher, P.; Strawbridge, J. A scoping review of health professional curricula: Implications for developing integration in pharmacy. Res. Soc. Adm. Pharm. 2020, 16, 1–16. [Google Scholar] [CrossRef]
- University of Waterloo School of Pharmacy. Co-operative Education. Available online: https://uwaterloo.ca/pharmacy/co-op-rotations-csl/co-operative-education (accessed on 29 April 2024).
- Cameron, A.J.; MacKeigan, L.D.; Mitsakakis, N.; A Pugsley, J.A. Multiple mini-interview predictive validity for performance on a pharmacy licensing examination. Med. Educ. 2017, 51, 379–389. [Google Scholar] [CrossRef] [PubMed]
- Daugherty, K.K.; Malcom, D.R. Assessing the relationship between didactic performance and standardized examination scores in pharmacy students. Am. J. Pharm. Educ. 2020, 84, 1123–1131. [Google Scholar] [CrossRef] [PubMed]
- Spivey, C.A.; Chisholm-Burns, M.A.; Johnson, J.L. Factors associated with student pharmacists’ academic progression and performance on the national licensure examination. Am. J. Pharm. Educ. 2020, 84, 269–276. [Google Scholar] [CrossRef]
- Mirza, N.; Manankil-Rankin, L.; Prentice, D.; Hagerman, L.-A.; Draenos, C. Practice readiness of new nursing graduates: A concept analysis. Nurse Educ. Pract. 2019, 37, 68–74. [Google Scholar] [CrossRef] [PubMed]
- Shah, S.; Peng, I.; Seifert, C.F. A model to predict NAPLEX outcomes and identify students needing additional preparation. Curr. Pharm. Teach. Learn. 2019, 11, 810–817. [Google Scholar] [CrossRef] [PubMed]
- Pharmacy Examining Board of Canada. Pharmacist Qualifying Examination. Available online: https://pebc.ca/pharmacists/qualifying-examination/preparing-for-the-examination/examination-blueprint/ (accessed on 29 April 2024).
- General Pharmaceutical Council. Registration as a Pharmacist. Available online: https://www.pharmacyregulation.org/pharmacists/registering-pharmacist (accessed on 25 May 2024).
- Australian Pharmacy Council. Exam Information. Available online: https://www.pharmacycouncil.org.au/pharmacist/exam-information/ (accessed on 25 May 2024).
- Northeastern University Bouve College of Health Sciences. Pharmacy Experiential Education & Co-op. Available online: https://bouve.northeastern.edu/pharmacy/co-op/ (accessed on 29 April 2024).
- University of Waterloo School of Pharmacy. Program Overview. Available online: https://uwaterloo.ca/pharmacy/co-op-rotations-csl/community-service-learning (accessed on 29 April 2024).
- Available online: https://uwaterloo.ca/pharmacy/co-op-rotations-csl/patient-care-rotations/patient-care-rotations-faq#What-are (accessed on 29 April 2024).
- Call, W.B.; Grice, G.R.; Tellor, K.B.; Armbruster, A.L.; Spurlock, A.M.; Berry, T.M. Predictors of student failure or poor performance on advanced pharmacy practice experiences. Am. J. Pharm. Educ. 2020, 84, ajpe7890. [Google Scholar] [CrossRef]
- Hastie, T.; Tibshirani, R.; Friedman, J.H. The Elements of Statistical Learning: Data Mining, Inference, and Prediction; Springer: Berlin/Heidelberg, Germany, 2009; Volume 2. [Google Scholar]
- Cor, M.K.; Brocks, D.R. Examining the relationship between prerequisite grades and types of academic performance in pharmacy school. Curr. Pharm. Teach. Learn. 2018, 10, 695–700. [Google Scholar] [CrossRef] [PubMed]
- McCall, K.L.; MacLaughlin, E.J.; Fike, D.S.; Ruiz, B. Preadmission predictors of PharmD graduates’ performance on the NAPLEX. Am. J. Pharm. Educ. 2007, 71, 05. [Google Scholar] [CrossRef] [PubMed]
- Allen, R.E.; Diaz, C. Use of preadmission criteria and performance in the doctor of pharmacy program to predict success on the North American Pharmacists Licensure Examination. Am. J. Pharm. Educ. 2013, 77, 193. [Google Scholar] [CrossRef] [PubMed]
- Garavalia, L.S.; Prabhu, S.; Chung, E.; Robinson, D.C. An analysis of the use of Pharmacy Curriculum Outcomes Assessment (PCOA) scores within one professional program. Curr. Pharm. Teach. Learn. 2017, 9, 178–184. [Google Scholar] [CrossRef] [PubMed]
- Elder, K.G.; Daugherty, K.K.; Malcom, D.R. Predicting NAPLEX scores using student performance in the clinical skills laboratory setting. Curr. Pharm. Teach. Learn. 2019, 11, 686–695. [Google Scholar] [CrossRef] [PubMed]
- Terry, R.; Hing, W.; Orr, R.; Milne, N. Do coursework summative assessments predict clinical performance? A systematic review. BMC Med. Educ. 2017, 17, 40. [Google Scholar] [CrossRef] [PubMed]
- Hernick, M.; Hylton, A.C.; Justice, M. A process for curricular improvement based on evaluation of student performance on milestone examinations. Am. J. Pharm. Educ. 2016, 80, 159. [Google Scholar] [CrossRef] [PubMed]
Evaluation | Assessment(s) and Minimum Performance Required to Pass |
---|---|
Didactic courses * | Final grade of 60% or higher |
Co-op work terms * | PharmD Inventory of Skills Evaluation (Supplementary Figure S2):
|
Midpoint assessment | Modified Angoff process used to set passing score (generally approximately 60%) |
Annual OSCE | Modified Angoff process used to set passing score (generally approximately 60%) |
Direct patient care rotations * | Overall grade of 70% or higher comprised of:
|
PEBC Pharmacist Qualifying Examination | MCQ and OSCE scores |
Course | Estimated Coefficient β | p-Value |
---|---|---|
OPPCAT only as predictor variable for rotation performance with PEBC MCQ as dependent variable | ||
PHARM 111: Anatomy and Physiology 2 | −3.46 | p = 0.001 |
PHARM 229: Professional Practice 4 | 3.87 | p = 0.03 |
PHARM 321: Integrated Patient-Focused Care 6 | −3.17 | p = 0.03 |
PHARM 324: Integrated Patient-Focused Care 8 | 3.95 | p = 0.002 |
PHARM 330: Professional Practice 6 | −2.89 | p = 0.04 |
Year 4 OSCE score | 1.55 | p = 0.03 |
Midpoint MCQ score | 2.50 | p < 0.001 |
Rotation 3 OPPCAT score | 1.74 | p = 0.04 |
OPPCAT only as predictor variable for rotation performance with PEBC OSCE as dependent variable | ||
PHARM 111: Anatomy and Physiology 2 | −2.98 | p = 0.01 |
PHARM 228: Professional Practice 3 | 2.40 | p = 0.04 |
PHARM 229: Professional Practice 4 | 3.72 | p = 0.04 |
PHARM 350: Fundamentals of Business Administration and Management | −2.39 | p = 0.05 |
PHARM 425: Symposium | 1.93 | p = 0.03 |
Rotation course overall as predictor variable for rotation performance with PEBC MCQ as dependent variable | ||
PHARM 111: Anatomy and Physiology 2 | −3.43 | p = 0.002 |
PHARM 229: Professional Practice 4 | 3.65 | p = 0.04 |
PHARM 321: Integrated Patient-Focused Care 6 | −3.15 | p = 0.03 |
PHARM 324: Integrated Patient-Focused Care 8 | 3.97 | p = 0.003 |
PHARM 330: Professional Practice 6 | −2.70 | p = 0.05 |
Year 4 OSCE score | 1.54 | p = 0.03 |
Midpoint MCQ score | 2.52 | p < 0.001 |
Rotation course overall as predictor variable for rotation performance with PEBC OSCE as dependent variable | ||
PHARM 111: Anatomy and Physiology 2 | −2.98 | p = 0.01 |
PHARM 228: Professional Practice 3 | 2.56 | p = 0.03 |
PHARM 229: Professional Practice 4 | 3.69 | p = 0.05 |
PHARM 350: Fundamentals of Business Administration and Management | −2.57 | p = 0.04 |
PHARM 425: Symposium | 1.93 | p = 0.03 |
Course | Estimated Coefficient β | p-Value |
---|---|---|
OPPCAT only from first completed rotation as dependent variable | ||
PHARM 222: Integrated Patient-Focused Care 3 | −0.29 | p = 0.02 |
PHARM 232: Medical Microbiology | −0.20 | p = 0.02 |
PHARM 422: Integrated Patient-Focused Care 9 | 0.32 | p < 0.001 |
OPPCAT only from second completed rotation as dependent variable | ||
Graduation year 2017 | 3.21 | p = 0.04 |
PHARM 124: Pharmaceutics 1 | 0.26 | p = 0.01 |
PHARM 220: Integrated Patient-Focused Care 1 | 0.28 | p = 0.02 |
PHARM 222: Integrated Patient-Focused Care 3 | −0.24 | p = 0.03 |
PHARM 227: Health Systems in Society | −0.23 | p < 0.001 |
PHARM 228: Professional Practice 3 | 0.33 | p < 0.001 |
OPPCAT only from third completed rotation as dependent variable | ||
PHARM 129: Professional Practice 1 | −0.20 | p = 0.04 |
PHARM 222: Integrated Patient-Focused Care 3 | −0.40 | p < 0.001 |
PHARM 350: Fundamentals of Business Administration & Management | 0.24 | p = 0.03 |
PHARM 422: Integrated Patient-Focused Care 9 | 0.28 | p < 0.001 |
CSPE overall (work term 1) | 0.84 | p = 0.03 |
Co-op direct patient care scores | 1.95 | p = 0.04 |
PHARM 430 (Primary Care) rotation overall score as dependent variable | ||
Graduation year 2018 | −2.44 | p = 0.03 |
PHARM 155: Drug Information Fundamentals | −0.19 | p = 0.02 |
PHARM 321: Integrated Patient-Focused Care 6 | 0.27 | p = 0.03 |
PHARM 422: Integrated Patient-Focused Care 9 | 0.22 | p < 0.001 |
PHARM 440 (Primary Care) rotation overall score as dependent variable | ||
Graduation year 2017 | 2.23 | p = 0.03 |
PHARM 124: Pharmaceutics 1 | 0.22 | p = 0.01 |
PHARM 125: Pharmaceutics 2 | −0.18 | p = 0.04 |
PHARM 228: Professional Practice 3 | 0.17 | p = 0.04 |
PHARM 232: Medical Microbiology | −0.17 | p = 0.01 |
PHARM 422: Integrated Patient-Focused Care 9 | 0.17 | p = 0.01 |
PHARM 450 (Elective) rotation overall score as dependent variable | ||
PHARM 129: Professional Practice 1 | −0.21 | p = 0.01 |
PHARM 222: Integrated Patient-Focused Care 3 | −0.38 | p < 0.001 |
PHARM 228: Professional Practice 3 | 0.22 | p = 0.01 |
PHARM 252: Institutional Pharmacy Practice | 0.16 | p = 0.04 |
PHARM 320: Integrated Patient-Focused Care 5 | 0.26 | p = 0.01 |
PHARM 422: Integrated Patient-Focused Care 9 | 0.22 | p < 0.001 |
PHARM 425: Symposium | 0.15 | p = 0.02 |
Year 1 OSCE score | −0.10 | p = 0.04 |
CSPE overall (work term 1) | 0.66 | p = 0.04 |
Co-op direct patient care scores | 2.07 | p = 0.01 |
Overall Co-Op Rating below Good across One or More Work Terms (n = 7) | Overall Co-Op Rating of Good across One or More Work Terms (n = 44) | Overall Co-Op Rating of Good or above across All Work Terms (n = 336) | Overall Co-Op Rating of Very Good or above across All Work Terms (n = 292) | |
---|---|---|---|---|
Performance in PharmD Program (n, %) | ||||
Failure of at least one course | 1 (14%) | 4 (9%) | 14 (4%) | 11 (4%) |
Near failure of at least one course | 5 (71%) | 31 (71%) | 183 (55%) | 157 (54%) |
Failure of at least one annual OSCE | 5 (71%) | 30 (68%) | 165 (49%) | 140 (48%) |
Near failure of at least one annual OSCE | 5 (71%) | 34 (77%) | 248 (74%) | 219 (75%) |
Failure of midpoint assessment | 2 (29%) | 7 (16%) | 46 (14%) | 41 (14%) |
Near failure of midpoint assessment | 3 (43%) | 25 (57%) | 117 (35%) | 95 (33%) |
Failure of at least one OPPCAT | 0 (0%) | 0 (0%) | 5 (2%) | 5 (2%) |
Near failure of at least one OPPCAT | 4 (57%) | 10 (23%) | 31 (9%) | 25 (9%) |
Performance on PEBC Pharmacist Qualifying Examination (n, %) | ||||
Failure of Part I (MCQ) | 3 (43%) | 6 (14%) * | 24 (7%) ± | 21 (7%) Δ |
Failure of Part II (OSCE) | 1 (14%) | 6 (14%) * | 11 (3%) ± | 6 (2%) Δ |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Syed, A.; Huang, Y.; Goh, J.; Moroz, S.; Pugsley, J.; Waite, N.M.; Houle, S.K.D. The Association between Academic Performance and Entry-to-Practice Milestones within a Co-Operative Education PharmD Program. Pharmacy 2024, 12, 90. https://doi.org/10.3390/pharmacy12030090
Syed A, Huang Y, Goh J, Moroz S, Pugsley J, Waite NM, Houle SKD. The Association between Academic Performance and Entry-to-Practice Milestones within a Co-Operative Education PharmD Program. Pharmacy. 2024; 12(3):90. https://doi.org/10.3390/pharmacy12030090
Chicago/Turabian StyleSyed, Ali, Yuying Huang, Joslin Goh, Sarah Moroz, John Pugsley, Nancy M. Waite, and Sherilyn K. D. Houle. 2024. "The Association between Academic Performance and Entry-to-Practice Milestones within a Co-Operative Education PharmD Program" Pharmacy 12, no. 3: 90. https://doi.org/10.3390/pharmacy12030090
APA StyleSyed, A., Huang, Y., Goh, J., Moroz, S., Pugsley, J., Waite, N. M., & Houle, S. K. D. (2024). The Association between Academic Performance and Entry-to-Practice Milestones within a Co-Operative Education PharmD Program. Pharmacy, 12(3), 90. https://doi.org/10.3390/pharmacy12030090